Apyx Medical Corporation APYX

Patients reported high satisfaction and visible improvements in skin elasticity, youthfulness, and radianceCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers o

Cold plasma offers opportunities in healthcare, food safety, agriculture, water treatment and manufacturing through chemical-free sterilization, surface engineering and AI-enabled automation.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Cold Plasma Market research report provides strategic analysis of a market projected to grow from USD 2.39 billion in 2026 to USD 4.09 billion by 2032, at a CAG

Cold plasma adoption is rising in healthcare for sterilization, wound healing and cancer care, with opportunities in infection control, food safety, textiles and eco-friendly processing.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market Size, Share & Trends Analysis Report by Pressure, Application, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. Global Cold Plasma Market to Reach USD 495.9 Million by 2033 as Healthcare Applications Expand

Company capitalizes on expanded FDA clearance and growing body contouring demand, reaffirming full-year guidance despite margin headwinds.

Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece for the AYON platform to key surgeons in critical geographies; initial commercial shipments in June 2026Reaffirmed total revenue guidance for FY2026 of $59.0 million to $60.0 millionManagement to host a conference call today at 4:30 p.m. ET CLEARWATER, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Apyx Medica

CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief Financial

CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the second quarter of fiscal year 2026 will be released after markets close on Thursday, August 6th. Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, August 6th, to discuss the results of

Apyx Medical Corporation (NASDAQ:APYX) is one of the high-growth micro-cap stocks to buy now. On May 21, Apyx Medical Corporation (NASDAQ:APYX) announced new clinical data in Aesthetic Surgery Journal Open Forum highlighting a promising approach to treating cellulite and skin laxity, two common concerns among women. The results were part of a clinical study evaluating […]

Apyx Medical’s fair value target has been nudged to US$6.50 from US$6.40, a small move that still gives you a fresh reference point for thinking about the stock. This adjustment sits against a backdrop of mixed Street commentary, where bulls focus on 2026 guidance, new products and international expansion, while more cautious voices highlight execution risks and higher expectations. Read on to see how these shifting price targets fit into the broader story and what to watch as the narrative...

Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.

Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.

Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.

EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.